Almitrine Bismesylate/Raubasine

二甲磺酸阿米三嗪/萝巴新

Report date: 2022/04/07 18:04:40

Base Information

Drug NameAlmitrine Bismesylate/Raubasine
Drug Alias Name阿米三嗪萝巴新片复方阿米三嗪片都可喜
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors antagonists
TargetsAdrenergic receptors
Therapy Area/IndicationsCognitive Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Almitrine BismesylateRaubasine
Global Highest StatusWithdrawn
Highest Status in ChinaWithdrawn
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChangzhou Pharmaceutical FactoryHenan Lantu Pharmaceutical Co LtdServier (Tianjin) Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsCognitive Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A